Koers W World Corp. OTC Markets

Aandelen

Vertraagde tijd OTC Markets Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^USD	-.--%		-.--%	-.--%

Duur

Periode

Stijl

Pharmos Corp. Designates Eric Fangmann as Acting President and Acting Chief Financial Officer	02-01-13
Pharmos Corp. Announces Management Changes	17-10-12
Pharmos Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2012	30-07-12
Pharmos Corp. Announces Successfully Completion of Proof-Of-Concept Clinical Trial Using its Compound Levotofisopam to Treat Patients with Hyperuricemia and Gout	17-05-12
Pharmos Corp. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2012	16-04-12